From lab to market: mastering real estate challenges for biotech success

Cushman & Wakefield's Locating Science life sciences report wins top award from the Society of Property Researchers

Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies designed to be safe, convenient, and precisely targeted, today announces it has established a UK subsidiary, based on the Oxford Science Park, as the company continues its development into an international leader in food allergies.

Facility dedicated to cryopreservation of leukapheresis starting materials to support clinical and commercial cell-based therapy programs

Logical Biological, a leading provider of biological critical materials for diagnostics, therapeutic research, and IVD reagent manufacture, has settled into larger, upgraded laboratory space at Discovery Park, marking its third move within the science and innovation campus.

Symbiosis Pharmaceutical Services Ltd announces the purchase of new premises in Stirling, Scotland, UK. The additional space will double the total footprint of the company across the four facilities that it will operate from, increasing manufacturing capacity by 50% in the short-term.

Ingenza, a world-leading contract research, development and manufacturing organisation (CRDMO) and technology accelerator, has signed a 10-year lease at the Moubray Building at Edinburgh Technopole, part of Pioneer Group.